Anniina Färkkilä, MD, PhD, Helsinki University, Helsinki, Finland, provides her highlights from the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2022, including talks on the immunogenicity of ovarian cancer and current advances in the development of vaccines for ovarian cancer. Dr Färkkilä additionally discusses the need for novel targets in breast cancer. This interview took place at the ESMO Immuno-Oncology Congress 2022 in Geneva, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.